Echtzeit-Aktienkurs Corium International
Bid:
Ask:
Echtzeit-Chart der Corium International Aktie
Fundamentaldaten der Corium International Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2017 [USD] | 31,86 Mio. | -47,79 Mio. | -47,79 Mio. | -1,64 | - | - | - |
| 2016 [USD] | 33,02 Mio. | -36,70 Mio. | -36,70 Mio. | -1,65 | - | - | - |
| 2015 [USD] | 40,92 Mio. | -28,45 Mio. | -28,45 Mio. | -1,52 | - | - | - |
| 2014 [USD] | 42,44 Mio. | -9,91 Mio. | -9,91 Mio. | -0,99 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Corium International Aktie
Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.